OTCMKTS:GLDFFGolden Leaf Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Golden Leaf Holdings Ltd Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $0.01 0.00 (0.00 %) (As of 07/10/2020 04:00 PM ET) Add Compare Share Today's Range$0.01Now: $0.01▼$0.0250-Day Range$0.01MA: $0.02▼$0.0252-Week Range$0.01Now: $0.01▼$0.05Volume353,700 shsAverage Volume543,477 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsHeadlinesSocial Media Golden Leaf Holdings Ltd., through its subsidiaries, produces, distributes, and sells cannabis oil and flower products. The company also research and development; ownership, administration, and leasing of real estate; ownership and leasing of capital equipment; and medical marijuana patient consulting activities. In addition, it operates a dispensary under the Left Coast Connections name. Golden Leaf Holdings Ltd. was incorporated in 2014 and is headquartered in Beaverton, Oregon.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Golden Leaf. Previous Next 2.4 Community Rank Outperform VotesGolden Leaf has received 84 “outperform” votes. (Add your “outperform” vote.)Underperform VotesGolden Leaf has received 93 “underperform” votes. (Add your “underperform” vote.)Community SentimentGolden Leaf has received 52.54% “underperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Golden Leaf and other stocks. Vote “Outperform” if you believe GLDFF will outperform the S&P 500 over the long term. Vote “Underperform” if you believe GLDFF will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldGolden Leaf does not currently pay a dividend.Dividend GrowthGolden Leaf does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Golden Leaf insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.48 out of 5 stars Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Drug Manufacturers - Specialty & Generic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:GLDFF Previous Symbol CUSIPN/A CIKN/A Webgoldenleafholdings.com Phone503-201-0659Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/APrice-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AProfitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees164 Outstanding SharesN/AMarket CapN/A Next Earnings DateN/A OptionableNot Optionable OTC:GLDFF Rates by TradingView Receive GLDFF News and Ratings via Email Sign-up to receive the latest news and ratings for GLDFF and its competitors with MarketBeat's FREE daily newsletter. Golden Leaf (OTCMKTS:GLDFF) Frequently Asked Questions How has Golden Leaf's stock been impacted by COVID-19 (Coronavirus)? Golden Leaf's stock was trading at $0.0140 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, GLDFF stock has increased by 0.0% and is now trading at $0.0140. View which stocks have been most impacted by Coronavirus. Has Golden Leaf been receiving favorable news coverage? News articles about GLDFF stock have been trending very negative recently, InfoTrie Sentiment reports. The research group identifies negative and positive news coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Golden Leaf earned a coverage optimism score of -3.2 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the company's share price in the next several days. View the latest news about Golden Leaf. Who are some of Golden Leaf's key competitors? Some companies that are related to Golden Leaf include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Ayr Strategies (AYRSF), Biome Grow (BIO), Blueberries Medical (BBM), Canbiola (CANB), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF), Cipher Pharmaceuticals (CPHRF) and CLS Holdings USA (CLSH). View all competitors. Who are Golden Leaf's key executives? Golden Leaf's management team includes the following people: Mr. William Simpson, Founder & Board ObserverMr. Mike Genovese, Chief Operating OfficerMr. William Kulczycki, Pres & CEOMs. Karyn O. Barsa, Chief Financial Officer (Age 58)Mr. John Anthony Magliana Jr., Corp. Gen. Counsel What is Golden Leaf's stock symbol? Golden Leaf trades on the OTCMKTS under the ticker symbol "GLDFF." How do I buy shares of Golden Leaf? Shares of GLDFF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Golden Leaf's stock price today? One share of GLDFF stock can currently be purchased for approximately $0.01. What is Golden Leaf's official website? The official website for Golden Leaf is goldenleafholdings.com. How can I contact Golden Leaf? The company can be reached via phone at 503-201-0659. This page was last updated on 7/13/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
